Source-grounded facts extracted from PMGC Holdings Inc.'s SEC 8-K filings across all families, newest first. Each cites a verbatim SEC excerpt.
PMGC Holdings Inc.: Amended Bylaws to classify Board of Directors into two staggered classes with three-year and one-year terms (effective 2026-06-05).
“On June 5, 2026, a majority of PMGC Holdings Inc. (the “Company”)’s shareholders approved of a Certificate of Amendment of the Company’s Bylaws (“Amended Bylaws”)”
PMGC Holdings Inc. shareholders approved Approve potential adjournment of Annual Meeting to solicit additional proxies at the 2026-06-05 meeting.
“Proposal 4 : Shareholders considered a proposal to approve the potential adjournment of the Annual Meeting to solicit additional proxies if required. The proposal was approved.* FOR* AGAINST ABSTAIN 6,527,449 13,200 24,185”
PMGC Holdings Inc. shareholders approved Ratify appointment of HTL International, LLC as independent registered public accounting firm for fiscal year ending December 31, 2026 at the 2026-06-05 meeting.
“Proposal 3 : Shareholders were asked to ratify the appointment of HTL International, LLC as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026. The proposal was approved. FOR AGAINST ABSTAIN 6,536,284 4,827 23,723”
PMGC Holdings Inc. shareholders approved Approve amendment to Bylaws to provide for a staggered Board of two classes at the 2026-06-05 meeting.
“Proposal No. 2 : to approve an amendment to the Company’s Bylaws to provide for a staggered Board comprised of two classes of directors, designated Class I and Class II, with Class I Directors serving for three (3) year terms and Class II Directors serving for one (1) year terms. FOR AGAINST ABSTAIN 6,525,599 15,443 23,792”
PMGC Holdings Inc. shareholders approved Election of five directors at the 2026-06-05 meeting.
“Proposal 1 : Five (5) directors were nominated for election to serve until the next annual meeting and until their successors are duly elected and qualified. Each nominee was elected. The voting results for each director were: Braeden Lichti FOR AGAINST ABSTAIN 6,526,627 14,410 23,797”
PMGC Holdings Inc. entered into Educational Research Agreement with Florida State University Research Foundation, Inc. valued at $490,657 (effective 2026-06-01).
“On June 1, 2026, NorthStrive Defense Tech entered into an Educational Research Agreement with FSURF (“Research Agreement”), in connection with the Term Sheet and to support continued development of the technology related to the Patent.”
PMGC Holdings Inc. entered into Term Sheet with Florida State University Research Foundation, Inc. (effective 2026-06-02).
“On June 2, 2026, NorthStrive Defense Tech LLC (“NorthStrive Defense Tech”), a wholly owned subsidiary of PMGC Holdings Inc. (the “Company”) entered into a binding term sheet (“Term Sheet”) with Florida State University Research Foundation, Inc. (“FSURF”), a Florida direct-support organization of Florida State University, pursuant to which FSURF will license patent rights related to U.S. Patent No. 12,291,334 (“Patent”) and the related know-how to NorthStrive Defense Tech.”
PMGC Holdings Inc. completed an acquisition involving A&B Aerospace, Inc. for $4,500,000 in cash (closed 2026-05-12).
“The Acquisition closed on May 12, 2026 (consummation of the Acquisition, “Closing” and such date, “Closing Date”). The purchase consideration for the Shares consisted of: (i) $4,500,000 in cash, of which $4,275,000 was paid to the Sellers at Closing (the “Closing Purchase Price”) and $225,000 was retained by the Company at Closing as an indemnification holdback”
PMGC Holdings Inc. issued 262,467 shares of Common Stock of common stock to Investor for $1,000,000 to the Company for the Registered Shares.
“Date was $10,000,000, computed as follows: $10,730,000.00 initial principal balance, less the OID, less the Transaction Expense Amount. In addition, Investor also agreed to pay $1,000,000 to the Company for the Registered Shares. The Company expects to consummate the Pre-Paid Purchase on or about April 17, 2026 and to receive net proceeds of $ 9,727,380.00 after”
PMGC Holdings Inc. issued convertible note to Investor for $10,730,000.00 initial principal balance, less the OID, less the Transaction Expense Amount.
“Purchase Agreement, upon the terms and subject to the limitations and conditions set forth in such Pre-Paid Purchase, as summarized herein: (i) an original principal amount of $10,730,000.00 (the “Pre-Paid Purchase Shares”); and (ii) an additional 262,467 shares of Common Stock (the “Registered Shares”). In connection with the Purchase Agreement, the Company also”
PMGC Holdings Inc. entered into Purchase Agreement with a certain investor ( valued at up to $40,000,000 (effective 2026-04-16).
“On April 16, 2026, the Company entered into a securities purchase agreement (the “Purchase Agreement”) with a certain investor (“Investor”).”
PMGC Holdings Inc. amended Third Amendment with MOA Life Plus Co., Ltd. (effective 2026-03-24).
“Northstrive Biosciences Inc. (“Northstrive”), a wholly owned subsidiary of PMGC Holdings Inc. (the “Company”), entered into a Third Amendment to License Agreement (the “Third Amendment”) with MOA Life Plus Co., Ltd. (“MOA”), a corporation organized under the laws of the Republic of Korea.”
PMGC Holdings Inc. issued 1-for-6 reverse stock split of common stock.
“PMGC Holdings Inc. (NASDAQ: ELAB) (“PMGC” or the “Company”) today announced that it will effect a 1-for-6 reverse stock split (the “Split”) of its issued and outstanding and authorized common stock, par value $0.0001 per share (“Common Stock”), effective at 12:00 am, Eastern time, on March 10, 2026.”
PMGC Holdings Inc.: 1-for-6 reverse stock split effective March 10, 2026, reducing authorized shares to 583,333,334 total (83,333,334 common + 500,000,000 preferred) (effective 2026-03-10).
“On March 4, 2026, PMGC Holdings Inc. (the “Company”) filed a Certificate of Amendment to the Company’s Articles of Incorporation, as amended (the “Certificate of Amendment”), to effect a 1-for-6 reverse stock split (the “Split”) of the shares of the Company’s authorized, issued, and outstanding shares of common stock, par value $0.0001 per share (“Common Stock”), such Split to be effective on March 10, 2026 at 12:00 a.m. Eastern Standard Time (the “Effective Time”).”
PMGC Holdings Inc. entered into Secured Pre-Paid Purchase #4 with an investor valued at $8,147,569.50 principal amount, $7,455,000 purchase price (effective 2026-02-06).
“On February 6, 2026 (“Effective Date”), the Company and an investor (“Investor”) consummated Secured Pre-Paid Purchase #4 (the “Fourth Pre-Paid Purchase”) under the previously disclosed equity purchase facility in the Company’s Current Report on Form 8-K filed with the U.S. Securities Exchange Commission (the “SEC”) on September 29, 2025, established pursuant to that certain Securities Purchase Agreement between the Company and the Investor dated September 23, 2025 (“Purchase Agreement”).”
PMGC Holdings Inc. entered into License Agreement with Modulant Biosciences LLC (effective 2026-02-04).
“On February 4, 2026, Northstrive Biosciences Inc., a Delaware corporation (“Northstrive Biosciences”) and wholly owned subsidiary of PMGC Holdings Inc. (“Company”), entered into the License Agreement (“License Agreement”) with Modulant Biosciences LLC (“Modulant,” and, together with Northstrive Biosciences, the “Parties”), an Indiana limited liability company.”
PMGC Holdings Inc. completed an acquisition involving SVM Machining, Inc. for aggregate purchase price for the Shares was 2,449,148.08 (closed 2026-02-02).
“sole stockholder of the Target (such stockholder, “Seller”). The Acquisition was consummated on February 2, 2026 (the “Closing”). The aggregate purchase price for the Shares was 2,449,148.08 (the “Purchase Price”) consisting of: 1) $2,250,000.00 in cash, of which $2,000,000.00 is payable to the Seller at Closing (the “Closing Purchase Price”), and $250,000.00”
PMGC Holdings Inc. entered into Third Pre-Paid Purchase valued at $5,464,500 (effective 2026-01-13).
“On January 13, 2026, the Company and an investor (“Investor”) consummated Secured Pre-Paid Purchase # 3 (the “Third Pre-Paid Purchase”) under the previously disclosed equity purchase facility in the Company’s Current Report on Form 8-K filed with the U.S. Securities Exchange Commission (“SEC”) on September 29, 2025, established pursuant to that certain Securities Purchase Agreement between the Company and the Investor dated September 23, 2025 (“Purchase Agreement”). As previously disclosed in the Company’s prospectus supplement (“Prospectus Supplement”) filed with the SEC on January 12, 2026, which supplements the Company’s registration statement (Registration No. 333-284505) filed with the SEC on January 24, 2025, declared effective by the SEC on February 7, 2025, the offering of the Company’s common stock, par value $0.0001, pursuant to the Prospectus Supplement, represents the Third Pre-Paid Purchase. The Third Pre-Paid Purchase has an original principal amount of $5,464,500 and an”
PMGC Holdings Inc. entered into Second Pre-Paid Purchase with Investor valued at original principal amount of $3,278,700 (effective 2026-01-07).
“On January 7, 2026, the Company and an investor (“Investor”) entered into and consummated Secured Pre-Paid Purchase # 2 (the “Second Pre-Paid Purchase”)”
PMGC Holdings Inc.: Filed Certificate of Amendment to Articles of Incorporation to effect a 4-for-1 reverse stock split of common stock, effective January 6, 2026 (effective 2026-01-06).
“On January 6, 2026, PMGC Holdings Inc. (the “Company”) filed a Certificate of Amendment to the Company’s Articles of Incorporation, as amended (the “Certificate of Amendment”), to effect a 4-for-1 reverse stock split (the “Split”) of the shares of the Company’s authorized, issued, and outstanding shares of common stock, par value $0.0001 per share (“Common Stock”), such Split to be effective on January 6, 2026 at 9:00 a.m. Eastern Standard Time (the “Effective Time”).”
PMGC Holdings Inc. completed an acquisition involving Indarg Engineering, Inc. for $548,000.00 (closed 2025-10-26).
“Current Report on Form 8-K (“Form 8-K”) but not otherwise defined have the meanings set forth in the Asset Purchase Agreement. The Purchase Price for the Purchased Assets was $548,000.00, payable at Closing as follows: (a) $350,000.00 to be used to satisfy and discharge Seller’s outstanding Small Business Administration loan; (b) $28,000.00 to be paid to Seller”
PMGC Holdings Inc. issued up to $20,000,000 aggregate purchase amount of common stock to an institutional investor for $20,000,000 Commitment Amount.
“aggregate purchase amount of up to $20,000,000 (such amount, the “Commitment Amount”)”
PMGC Holdings Inc. issued 10,300 shares of Common Stock of common stock to an institutional investor for $6.70 per share.
“follows: $5,000,000.00 initial principal balance, less the OID, less the Transaction Expense Amount. In addition to the Initial Purchase Price, the Investor also agreed to pay $6.70 to Company for the Pre-Delivery Shares (the “Pre-Delivery Purchase Price,” and, together with the Initial Purchase Price, the “Purchase Price”). The maturity date of the Initial”
PMGC Holdings Inc. issued 56,700 shares of Common Stock of common stock to an institutional investor for $5,000,000 initial principal balance, less OID and Transaction Expense Amount.
“and conditions set forth in such Pre-Paid Purchase (as further described below); (ii) Pre-Paid Purchase # 1 (the “Initial Pre-Paid Purchase”) in the original principal amount of $5,000,000, to be delivered by the Company to the Investor on the date of consummation of the issuance and sale of the Initial Pre-Paid Purchase and the Pre-Delivery Shares (such”
PMGC Holdings Inc.: Certificate of Amendment increasing authorized share capital to 2,500,000,000 shares, comprised of 2,000,000,000 shares of common stock and 500,000,000 shares of preferred stock (effective 2025-09-15).
“On September 15, 2025, PMGC Holdings Inc. (the “Company”) filed a Certificate of Amendment (the “Amendment”) to its Articles of Incorporation with the Secretary of State of the State of Nevada. The Amendment increases the authorized share capital of the Company to a total of 2,500,000,000 (two billion five hundred million) shares, consisting of 2,000,000,000 (two billion) shares of common stock, par value of $0.0001 per share, and 500,000,000 shares of preferred stock, par value of $0.0001 per share.”
PMGC Holdings Inc. completed an acquisition involving Jeffrey Uhrig for $650,000 in cash (closed 2025-07-18).
“the Target and Jeffrey Uhrig, the sole member of the Target (the “Seller”). The Acquisition closed on July 18, 2025. The purchase consideration for the Units consisted of $650,000 in cash paid by the Buyer to the Seller at the closing of the Acquisition (the “Closing”). Pursuant to the Acquisition Agreement, the Seller agreed to non-competition and”
PMGC Holdings Inc. completed an acquisition involving Pacific Sun Packaging Inc. for $1,148,000 in cash paid by the Buyer to the stockholder of Target at the Closing; and (ii) a contingent earnout payment of up to $250,000 (closed 2025-07-07).
“Agreement”), by and between the Buyer and the Target. The Acquisition closed on July 7, 2025 (the “Closing”). The purchase consideration for the Shares consisted of: (i) $1,148,000 in cash paid by the Buyer to the stockholder of Target at the Closing; and (ii) a contingent earnout payment of up to $250,000, payable to the stockholder of the Target if the”
PMGC Holdings Inc.: Filed a Certificate of Amendment to effect a 1-for-7 reverse stock split of common stock, effective March 10, 2025 (effective 2025-03-10).
“On February 28, 2025, PMGC Holdings Inc. (the “Company”) filed a Certificate of Amendment to the Company’s Articles of Incorporation, as amended (the “Certificate of Amendment”), to effect a 1-for-7 reverse stock split (the “Split”) of the shares of the Company’s common stock, par value $0.0001 per share (“Common Stock”), to be effective on March 10, 2025.”
PMGC Holdings Inc.: Filed Certificate of Amendment to the Amended and Restated COD, increasing authorized Series B Preferred Stock from 50 million to 300 million shares (effective 2025-02-24).
“On February 24, 2025, the Company filed the Certificate of Amendment to the Amended and Restated COD with the Nevada Secretary of State (the "Certificate of Amendment to the COD").”
PMGC Holdings Inc.: Filed Amended and Restated Certificate of Designations for Series B Preferred Stock, removing conversion rights and clarifying dividend, liquidation, voting and protective provisions (effective 2025-02-21).
“On February 21, 2025, PMGC Holdings Inc. (the "Company") filed the Amended and Restated Certificate of Designations, Rights, and Preferences of the Series B Preferred Stock (the "Amended and Restated COD") with the Secretary of State of the State of Nevada (the "Nevada Secretary of State").”
PMGC Holdings Inc. completed a disposition involving Cutis Cura Corporation (Buyer) and Carmell Corporation ("CTCX") for total purchase price for the Disposed Assets was approximately $1.4 million (closed 2025-01-16).
“and Exchange Commission (the “SEC”) on January 7, 2025. Upon the closing of the Disposition (the “Closing”), the total purchase price for the Disposed Assets was approximately $1.4 million, consisting of (i) 1,149,226 shares of common stock, par value $0.0001 per share, of CTCX (“CTCX Common Stock”), issued by CTCX to the Seller at the Closing, as well as 117,814”
PMGC Holdings Inc. engaged HTL International, LLC as its auditor.
“Effective December 20, 2024, the Company engaged HTL International, LLC (“HTL”) as its new independent registered public accounting firm.”
PMGC Holdings Inc. dismissed TPS Thayer, LLC as its auditor.
“On December 17, 2024, Elevai Labs Inc. (now PMGC Holdings Inc.) (the “Company”) dismissed TPS Thayer, LLC (“TPS”) as its independent registered public accounting firm.”
PMGC Holdings Inc.: Changed quorum requirement for shareholder meetings from a majority to one-third of voting power (effective 2024-11-20).
“On November 20, 2024, Elevai Labs Inc. (the “Company”) the Company amended its amended and restated bylaws (“Bylaws”) to change the quorum requirement for shareholder meetings from a majority to one-third (1/3) of the voting power of the Company’s outstanding shares entitled to vote at a meeting.”
PMGC Holdings Inc.: Amendment to Certificate of Incorporation to effect a 1-for-200 reverse stock split (effective 2024-11-27).
“On November 20, 2024, Elevai Labs Inc. (the “Company”) filed a Certificate of Amendment to the Company’s Third and Amended Certificate of Incorporation, as amended (the “Certificate of Amendment”), to effect a 1-for-200 reverse stock split (the “Split”) of the shares of the Company’s common stock, par value $0.0001 per share (“Common Stock”), on November 27, 2024.”
PMGC Holdings Inc.: Effected a 1-for-200 reverse stock split of common stock (effective 2024-11-27).
“On November 20, 2024, Elevai Labs Inc. (the “Company”) filed a Certificate of Amendment to the Company’s Third and Amended Certificate of Incorporation, as amended (the “Certificate of Amendment”), to effect a 1-for-200 reverse stock split (the “reverse stock split”) of the shares of the Company’s common stock, par value $0.0001 per share (the “Common Stock”), on November 27, 2024.”
Hatem Abou-Sayed resigned as Chief Medical Officer at PMGC Holdings Inc..
“On August 1, 2024, Hatem Abou-Sayed MD informed Elevai Labs Inc. (the “Company”) of his decision to resign as a member of the Board of Directors of the Company and as Chief Medical Officer effective as of August 1, 2024.”
Hatem Abou-Sayed resigned as member of the Board of Directors at PMGC Holdings Inc..
“On August 1, 2024, Hatem Abou-Sayed MD informed Elevai Labs Inc. (the “Company”) of his decision to resign as a member of the Board of Directors of the Company and as Chief Medical Officer effective as of August 1, 2024.”
Braeden Lichti was appointed as non-executive chairman and director at PMGC Holdings Inc..
“the Board appointed Mr. Braeden Lichti, as non-executive chairman and director of the Board”
Graydon Bensler was appointed as non-employee Chief Executive Officer at PMGC Holdings Inc..
“the Board appointed our current chief financial officer and director, Mr. Graydon Bensler, as non-employee Chief Executive Officer of the Company.”
Christoph Kraneiss departed as chief commercial officer at PMGC Holdings Inc..
“On June 20, 2024, we notified Brenda Buechler, our chief marketing officer, and Christoph Kraneiss, our chief commercial officer that each of them was involuntarily terminated without ‘cause’ or laid off from employment as part of a wider job elimination/restructuring or reduction in force of the Company in order to streamline the Company’s operations and organizational structure.”
Brenda Buechler departed as chief marketing officer at PMGC Holdings Inc..
“On June 20, 2024, we notified Brenda Buechler, our chief marketing officer, and Christoph Kraneiss, our chief commercial officer that each of them was involuntarily terminated without ‘cause’ or laid off from employment as part of a wider job elimination/restructuring or reduction in force of the Company in order to streamline the Company’s operations and organizational structure.”
Dr. Jordan Plews resigned as chief executive officer at PMGC Holdings Inc..
“Dr. Jordan Plews, notified the board of directors of the Company (the “Board”) of his intention to resign as chief executive officer of the Company , effective on the close of business on June 21, 2024.”
PMGC Holdings Inc. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5450(a)(1), 5810(c)(3)(A)).
“March 6, 2024, Elevai Labs Inc. (the “Company”), received written notice (the “Notice”) from the Listing Qualifications Department of the Nasdaq Stock Market, LLC (“Nasdaq ”) notifying the Company that, based on the closing bid price of the Company’s common stock, par value $0.0001 per share (the “Common Stock”), for the last 30 consecutive trading days, the Company no longer complies with the minimum bid price requirement for continued listing on the Nasdaq Capital Market. Nasdaq Listing Rule 5450(a)(1) requires listed securities to maintain a minimum bid price of $1.00 per share (the “Minimu”
George Kovalyov was appointed as Director at PMGC Holdings Inc..
“the Board appointed Mr. George Kovalyov, as independent director of the Company, as a member of the audit and nomination committee of the Board, and as chairman to the Compensation Committee.”
Crystal Muilenburg resigned as Director at PMGC Holdings Inc..
“On March 1, 2024, Ms. Crystal Muilenburg, an independent director of the Company notified the board of directors of the Company (the “Board”) of her intention to resign as a director and as chair of the compensation committee of the Company (the “Compensation Committee”) and as a member of the nominating and audit committees of the Company , effective on March 1, 2024.”
Facts are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.